Regeneron (REGN) Tops Q1 EPS by $1.45
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $894.09 -1.37%
EPS Growth %: +0.3%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
DGICA, UXIN, TOWN, More
EPS Growth %: +0.3%
Financial Fact:
Net loss before income tax benefit: 365.88M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $11.49, $1.45 better than the analyst estimate of $10.04. Revenue for the quarter came in at $2.97 billion versus the consensus estimate of $2.73 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $1,030 at TD Cowen
- Cullen/Frost Bankers (CFR) Misses Q1 EPS by 3c
- First Merchants Corp (FRME) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
